Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.

IF 9.6 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
American journal of public health Pub Date : 2024-11-01 Epub Date: 2024-10-03 DOI:10.2105/AJPH.2024.307721
Michael J Armstrong
{"title":"Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.","authors":"Michael J Armstrong","doi":"10.2105/AJPH.2024.307721","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives.</b> To estimate changes in medical cannabis patient activity after Canada's recreational cannabis legalization. <b>Methods.</b> I used linear regressions of interrupted times series models to analyze medical cannabis patient registrations per 10 000 residents, purchases per 100 registrations, and packages per purchase in Canada's 10 provinces between April 2017 and December 2022. I tested relationships between the recreational law's passage in June 2018, recreational sales starting in October 2018, and the arrival of edibles and vapes in December 2019. <b>Results.</b> Medical patient registrations initially increased; they slowed after the law passed and started decreasing after edibles became available. Medical purchasing frequencies initially decreased; they decreased further in proportion to recreational sales but stabilized after edibles became available. Medical purchase sizes were initially stable; they began increasing after edibles became available. <b>Conclusions.</b> Canada saw substantial decreases in medical cannabis patient registrations, but the remaining patients stabilized their purchasing frequencies and increased their purchase sizes. <b>Public Health Implications.</b> Other countries might see significant changes in patient usage of their medical cannabis systems after nationwide recreational cannabis legalization. (<i>Am J Public Health</i>. 2024;114(S8):S673-S680. https://doi.org/10.2105/AJPH.2024.307721).</p>","PeriodicalId":7647,"journal":{"name":"American journal of public health","volume":" ","pages":"S673-S680"},"PeriodicalIF":9.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11499694/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of public health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2105/AJPH.2024.307721","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives. To estimate changes in medical cannabis patient activity after Canada's recreational cannabis legalization. Methods. I used linear regressions of interrupted times series models to analyze medical cannabis patient registrations per 10 000 residents, purchases per 100 registrations, and packages per purchase in Canada's 10 provinces between April 2017 and December 2022. I tested relationships between the recreational law's passage in June 2018, recreational sales starting in October 2018, and the arrival of edibles and vapes in December 2019. Results. Medical patient registrations initially increased; they slowed after the law passed and started decreasing after edibles became available. Medical purchasing frequencies initially decreased; they decreased further in proportion to recreational sales but stabilized after edibles became available. Medical purchase sizes were initially stable; they began increasing after edibles became available. Conclusions. Canada saw substantial decreases in medical cannabis patient registrations, but the remaining patients stabilized their purchasing frequencies and increased their purchase sizes. Public Health Implications. Other countries might see significant changes in patient usage of their medical cannabis systems after nationwide recreational cannabis legalization. (Am J Public Health. 2024;114(S8):S673-S680. https://doi.org/10.2105/AJPH.2024.307721).

2017-2022 年加拿大休闲大麻合法化和医用大麻患者活动。
目标。估计加拿大娱乐大麻合法化后医用大麻患者活动的变化。方法。我使用间断时间序列模型的线性回归分析了 2017 年 4 月至 2022 年 12 月期间加拿大 10 个省每 10 000 名居民中的医用大麻患者注册人数、每 100 名注册人数中的购买人数以及每次购买的包装数量。我测试了 2018 年 6 月通过娱乐法、2018 年 10 月开始娱乐销售以及 2019 年 12 月食用大麻和吸食大麻的到来之间的关系。结果显示医疗患者的注册人数最初有所增加;法律通过后,注册人数有所放缓,而在药剂开始供应后,注册人数开始减少。医用购买频率最初有所下降;与娱乐销售相比,购买频率进一步下降,但在可食用大麻上市后趋于稳定。医用大麻的购买量起初比较稳定;在食用大麻上市后,购买量开始增加。结论。加拿大医用大麻患者注册人数大幅减少,但剩余患者的购买频率趋于稳定,购买量有所增加。对公共卫生的影响。在全国范围内娱乐大麻合法化之后,其他国家的医用大麻患者使用情况可能会发生重大变化。(Am J Public Health.https://doi.org/10.2105/AJPH.2024.307721 )。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of public health
American journal of public health 医学-公共卫生、环境卫生与职业卫生
CiteScore
9.50
自引率
3.90%
发文量
1109
审稿时长
2-4 weeks
期刊介绍: The American Journal of Public Health (AJPH) is dedicated to publishing original work in research, research methods, and program evaluation within the field of public health. The journal's mission is to advance public health research, policy, practice, and education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信